Adverse Event reporting information can be found in footer
Request a Meeting
Ferring Pharmaceuticals Ltd. has been supplying medicines in obstetrics for over 25 years. The current product portfolio has treatments for induction of labour and prevention of postpartum haemorrhage due to uterine atony.
On this website you can find information and educational resources on our products and therapy areas, along with the prescribing information.
Dinoprostone is indicated for initiation of cervical ripening in patients from 37 completed weeks of gestation.1
Learn More Prescribing InformationPabal® is indicated for the prevention of postpartum haemorrhage due to uterine atony.2
Prescribing InformationTractocile® is indicated to delay imminent pre-term birth in pregnant adult women.3
Prescribing InformationThe Ferring Philosophy places people at the heart of what we do. Our philosophy and values determine not just what we do, but how we conduct ourselves in the marketplace, with our patients, employees, regulators, business partners and local communities.
We aim to listen with respect and act with integrity.
Making a difference to people’s health and quality of life, today and tomorrow.
Learn MoreJob Code: UK-RMMH-2300024 - Date of preparation: December 2023